Monroe, New York (NY) Commercial Biotechnical Research Companies
Featured companies
OyaGen, Inc is a drug development company focused on bringing to market novel therapeutics in the path toward a functional cure for HIV/AIDS
Not satisfied? Select a reason•Rate this page•Send feedback
Or try our search form or quick navigation by category and location
Whereorg has 6 results under Commercial Biotechnical Research Companies in Monroe.
Other categories for location Monroe, New York
All industries
Professional Services Commercial Physical and Biological Research Commercial Biotechnical Research
Select a location for category Commercial Biotechnical Research
Quick navigation
All industries
Professional Services
Commercial Physical and Biological Research
Commercial Biotechnical Research
Subcategory
- Biological Research4
- Commercial Medical Research5
- Commercial Physical Research2
- Commercial Research Laboratory6
- Computer (Hardware) Development5
- Electronic Research and Development5
- Energy Research89
- Engineering Laboratory, Except Testing1
- Environmental and Ecological Services101
- Experimental Work1
- Industrial Laboratory, Except Testing1
- Laboratories7
- Natural Resource Research1
- Recycling Consultants2
- Research and Development Laboratories125
- Technology Assistance Programs1
City or suburb
Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020